Clinical Trials Directory

Trials / Completed

CompletedNCT01292486

Evaluation of the Spectra Optia® Mononuclear Cell Collection Procedure

Evaluation of the Spectra Optia® Apheresis System Mononuclear Cell (MNC) Collection Procedure in Multiple Myeloma Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
32 (actual)
Sponsor
Terumo BCT · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this investigation is to establish that hematopoetic stem cells collected on a new centrifugal blood separator, CaridianBCT's Spectra Optia Apheresis System, are able to reconstitute the hematopoetic systems of patients treated with myeloablative therapy, equivalent to hematopoetic cells harvested on the predicate COBE® Spectra platform.

Detailed description

This is a multi-center (3-5) single-arm study that will compare the performance of the Spectra Optia Apheresis System's MNC protocol to that of the historical performance of the COBE Spectra MNC protocol. In order to demonstrate the substantial equivalence of the two devices, a non-inferiority design will be used. The study will enroll patients with multiple myeloma who are to be treated with myeloablative chemotherapy, followed by bone-marrow rescue with an autologous peripheral blood stem-cell transplant. Peripheral blood stem cells will be collected using the Spectra Optia MNC protocol and re-infused following myeloablative chemotherapy.

Conditions

Interventions

TypeNameDescription
DEVICESpectra Optia Apheresis SystemIn this study, the safety and effectiveness of the new device will be assessed in two ways. First, MNC collections in growth-factor mobilized cancer patients will be evaluated to confirm that the Spectra Optia is able to collect stem cells. Second, following stem-cell collection and transplant, the number of days required for the collected hematopoetic stem cells to engraft/recover will be compared with historical COBE Spectra engraftment/recovery data.

Timeline

Start date
2011-02-01
Primary completion
2011-11-01
Completion
2011-12-01
First posted
2011-02-09
Last updated
2013-05-01
Results posted
2013-05-01

Locations

4 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01292486. Inclusion in this directory is not an endorsement.